Benefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM)

Schön Klinik Berchtesgadener Land

Status: Completed

Conditions: LAM; Lymphangioleiomyomatosis; Pulmonary Rehabilitation

Treatments: Other: Pulmonary Rehabilitation

Study type: Observational

Funder types: Other

Identifiers

NCT04184193

LAM Trial

Details and patient eligibility

About

Data from patients with the orphan disease of lymphangioleiomyomatosis (LAM) which performed a pulmonary Rehabilitation program will be analyzed retrospectively. Data will be taken from the internal data base of the reference Center (Schoen Klinik Berchtesgadener Land, Schoenau, Germany) where These data were collected during clinical routine. Data will be included from the year 2000 until now. A retrospectively matched COPD cohort will be included for comparison.

Enrollment: 58 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• confirmed diagnosis of Lymphangioleiomyomatosis
• performed a pulmonary Rehabilitation program at the reference center

Exclusion criteria

• missing data
• repeated stay for pulmonary Rehabilitation at the reference center

Trial design

58 participants in 1 patient group

Pulmonary Rehabilitation

Treatment:

Other: Pulmonary Rehabilitation